Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$26.39 USD
+0.03 (0.11%)
Updated Jul 22, 2024 04:00 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
XRAY 26.39 +0.03(0.11%)
Will XRAY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for XRAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XRAY
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
What's in Store for Patterson Companies (PDCO) in Q4 Earnings?
XRAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Understanding Dentsply (XRAY) Reliance on International Revenue
DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q1 Earnings
Other News for XRAY
Dentsply Sirona price target lowered by $2 at Baird, here's why
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 10 Analysts
Dentsply Sirona price target lowered by $2 at Stifel, here's why
Dentsply Sirona to Host Second Quarter Conference Call on July 31st
First Week of August 16th Options Trading For DENTSPLY SIRONA (XRAY)